ZEBETA Drug Patent Profile
✉ Email this page to a colleague
When do Zebeta patents expire, and what generic alternatives are available?
Zebeta is a drug marketed by Teva Womens and is included in one NDA.
The generic ingredient in ZEBETA is bisoprolol fumarate. There are twelve drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the bisoprolol fumarate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Zebeta
A generic version of ZEBETA was approved as bisoprolol fumarate by RUBICON on November 16th, 2000.
Summary for ZEBETA
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 212 |
Clinical Trials: | 3 |
Patent Applications: | 3,310 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ZEBETA at DailyMed |
Recent Clinical Trials for ZEBETA
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Heart Center BH Tuzla | Early Phase 1 |
IPCA Laboratories Ltd. | Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for ZEBETA
US Patents and Regulatory Information for ZEBETA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva Womens | ZEBETA | bisoprolol fumarate | TABLET;ORAL | 019982-002 | Jul 31, 1992 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Teva Womens | ZEBETA | bisoprolol fumarate | TABLET;ORAL | 019982-001 | Jul 31, 1992 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ZEBETA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Teva Womens | ZEBETA | bisoprolol fumarate | TABLET;ORAL | 019982-002 | Jul 31, 1992 | ⤷ Try a Trial | ⤷ Try a Trial |
Teva Womens | ZEBETA | bisoprolol fumarate | TABLET;ORAL | 019982-001 | Jul 31, 1992 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ZEBETA
See the table below for patents covering ZEBETA around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Singapore | 7192 | ⤷ Try a Trial | |
Japan | S6210220 | ⤷ Try a Trial | |
Spain | 463022 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |